Virus Cases Rise As Booster Tips Approach | Mandurah Courier


Victoria has seen a slight increase in her daily COVID-19 cases, and infections in New South Wales continue to decline steadily as attention turns to the rollout of booster vaccines across the country.

There were 1,510 new cases reported by Victoria on Tuesday and four deaths.

There are now 817 Victorians hospitalized with COVID, including 147 in intensive care, including 88 on a ventilator.

However, new figures have shown that three-quarters of the over-16s in the state have been fully immunized.

In New South Wales, there have been 282 new local cases and two in hotel quarantine, while there has been one additional death.

Hospital admissions declined to 457, including 109 in intensive care.

Immunization rates continue to rise, with the state now accounting for 85% of its over-16s who are fully vaccinated.

Queensland has also recorded two new COVID-19 infections, including a teenager from the Gold Coast who is in close contact with a domestic case, while the second is in home quarantine.

State health officials also said a truck driver tested positive interstate but was contagious while in Queensland.

There have been 12 new cases reported in ACT, with the capital now having 89.3% of its over-12s fully vaccinated.

The new virus numbers are coming as the focus shifts to COVID-19 booster injections and their deployment to the general public.

Meetings were held on Monday by the Medical Regulator’s National Vaccines Committee and the Australian Immunization Technical Advisory Group to discuss whether to approve a third dose.

Although booster shots have already been made available to severely immunocompromised Australians, they have yet to be approved for the general public.

Infectious disease expert Peter Collignon said mixing and matching of vaccine brands for booster shots would be “inevitable.”

He told the Seven Network that it was likely that some Australians would get a different brand of vaccine for their third dose than their first two when the booster shots are approved.

“We don’t yet know how to best combine and match, but we can get data from North America,” Professor Collignon said.

“Summer is likely to have a lot less transmission than next winter, so we have about four or five months to get a response to that.”

The medical regulator will review data regarding overseas booster injections before a final decision is made.

A spokeswoman for the Therapeutic Goods Administration told the AAP that an approval decision was made as a priority and is expected to be finalized in the coming days.

It is likely that mRNA vaccines, such as Pfizer and Moderna, will be primarily used for third doses of vaccine.

Associated Australian Press

About Ethel Nester

Check Also

Mixing ibuprofen with common blood pressure medications can cause permanent kidney damage

WATERLOO, Ontario (StudyFinds.org) – If you’re currently taking a diuretic and a renin-angiotensin system (RSA) …

Leave a Reply

Your email address will not be published.